Gene · 83990
Papers4,271
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
301 to 320 of 4,271
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Molecular profiling and feasibility using a comprehensive hybrid capture panel on a consecutive series of non-small-cell lung cancer patients from a single centre. | ESMO Open | 2023 | 38070435 | PubTator, text mining | PubMed |
| Early-Onset Ovarian Cancer <30 Years: What Do We Know about Its Genetic Predisposition? | Int J Mol Sci | 2023 | 38069345 | PubTator, text mining | PubMed |
| The Advantages of Next-Generation Sequencing Molecular Classification in Endometrial Cancer Diagnosis. | J Clin Med | 2023 | 38068290 | PubTator, text mining | PubMed |
| Comparing Prognosis for BRCA1, BRCA2, and Non-BRCA Breast Cancer. | Cancers (Basel) | 2023 | 38067403 | PubTator, text mining | PubMed |
| Gaps and Opportunities in the Diagnosis and Treatment of Pancreatic Cancer. | Cancers (Basel) | 2023 | 38067280 | PubTator, text mining | PubMed |
| Concordance between Three Homologous Recombination Deficiency (HRD) Assays in Patients with High-Grade Epithelial Ovarian Cancer. | Cancers (Basel) | 2023 | 38067228 | PubTator, text mining | PubMed |
| Cancer Risk Factors in Southern Brazil: Report of a Comprehensive, Matched Case-Control Study. | JCO Glob Oncol | 2023 | 38060977 | PubTator, text mining | PubMed |
| Epidemiological and Clinical Characteristics of Young Patients With Breast Cancer in Brazil: A Retrospective Study. | JCO Glob Oncol | 2023 | 38060974 | PubTator, text mining | PubMed |
| Identification and validation of M2 macrophage-related genes in endometriosis. | Heliyon | 2023 | 38058639 | PubTator, text mining | PubMed |
| Clinical and functional analysis of the germline TP53 p.K164E acetylation site variant. | Cold Spring Harb Mol Case Stud | 2023 | 38050059 | PubTator, text mining | PubMed |
| The enrichment of Fanconi anemia/homologous recombination pathway aberrations in ATM/ATR-mutated NSCLC was accompanied by unique molecular features and poor prognosis. | J Transl Med | 2023 | 38041093 | PubTator, text mining | PubMed |
| CYP4B1 polymorphisms and the risk of breast cancer in Chinese women: a case-control study. | BMC Cancer | 2023 | 38041008 | PubTator, text mining | PubMed |
| Homologous Recombination Deficiency Across Subtypes of Primary Breast Cancer. | JCO Precis Oncol | 2023 | 38039432 | PubTator, text mining | PubMed |
| Concepts of multi-level dynamical modelling: understanding mechanisms of squamous cell carcinoma development in Fanconi anemia. | Front Genet | 2023 | 38028610 | PubTator, text mining | PubMed |
| The microtubule inhibitor eribulin demonstrates efficacy in platinum-resistant and refractory high-grade serous ovarian cancer patient-derived xenograft models. | Ther Adv Med Oncol | 2023 | 38028140 | PubTator, text mining | PubMed |
| Establishing a novel Fanconi anemia signaling pathway-associated prognostic model and tumor clustering for pediatric acute myeloid leukemia patients. | Open Med (Wars) | 2023 | 38025539 | PubTator, text mining | PubMed |
| Loss of chromosome 9p21 is associated with a poor prognosis in adenosquamous carcinoma of the pancreas. | Precis Clin Med | 2023 | 38024139 | PubTator, text mining | PubMed |
| Network-targeting combination therapy of leptomeningeal glioblastoma using multiple synthetic lethal strategies: a case report. | Front Oncol | 2023 | 38023264 | PubTator, text mining | PubMed |
| Fanconi anemia pathway regulation by FANCI in prostate cancer. | Front Oncol | 2023 | 38023254 | PubTator, text mining | PubMed |
| Analysis of Turkish Breast Cancer Patients With ATM-Heterozygous Germline Mutation According to Clinicopathological Features. | Cureus | 2023 | 38021491 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/83990/papers?page=16